Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Tuesday, December 31, 2024.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2024-12-31.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-401.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-245.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-207.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-398.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-200.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-165.27%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tiziana Life Sciences Ltd
Market Cap
$68.08M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-401.98%
3Y Avg
-245.26%
5Y Avg
-207.94%
Market Cap
$68.43M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
Market Cap
$68.32M
Return on Invested Capital (ROIC)
13.12%
TTM Avg
-58.05%
3Y Avg
-35.80%
5Y Avg
-42.97%
Market Cap
$67.52M
Return on Invested Capital (ROIC)
-40.22%
TTM Avg
-72.23%
3Y Avg
-74.75%
5Y Avg
-58.95%
Market Cap
$69.75M
Return on Invested Capital (ROIC)
-6.75%
TTM Avg
20.47%
3Y Avg
-36.30%
5Y Avg
-23.36%
Market Cap
$66.31M
Return on Invested Capital (ROIC)
-37.01%
TTM Avg
-30.52%
3Y Avg
-23.08%
5Y Avg
-17.79%
Market Cap
$66.20M
Return on Invested Capital (ROIC)
-83.74%
TTM Avg
-153.15%
3Y Avg
-164.21%
5Y Avg
-165.99%
Market Cap
$64.80M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-86.10%
3Y Avg
-83.22%
5Y Avg
-74.34%
Market Cap
$72.09M
Return on Invested Capital (ROIC)
-159.24%
TTM Avg
-170.07%
3Y Avg
-147.54%
5Y Avg
-112.39%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tiziana Life Sciences Ltd (TLSA) | $68.08M | N/A | -401.98% | -245.26% | -207.94% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.43M | -10.85% | -101.00% | -120.85% | -96.47% |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.32M | 13.12% | -58.05% | -35.80% | -42.97% |
| iBio, Inc. (IBIO)vs › | $67.52M | -40.22% | -72.23% | -74.75% | -58.95% |
| Champions Oncology, Inc. (CSBR)vs › | $69.75M | -6.75% | 20.47% | -36.30% | -23.36% |
| XBiotech Inc. (XBIT)vs › | $66.31M | -37.01% | -30.52% | -23.08% | -17.79% |
| Cingulate Inc. (CING)vs › | $66.20M | -83.74% | -153.15% | -164.21% | -165.99% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.80M | N/A | -86.10% | -83.22% | -74.34% |
| Gain Therapeutics, Inc. (GANX)vs › | $72.09M | -159.24% | -170.07% | -147.54% | -112.39% |
| MindWalk Holdings Corp. (HYFT)vs › | $72.34M | -153.46% | -63.13% | -47.00% | -35.71% |
ROIC
N/A
ROE
-35444.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2024-12-31 | -401.27% |
| 2023-12-31 | -402.69% |
| 2022-12-31 | -90.48% |
| 2021-12-31 | -86.61% |
| 2020-12-31 | -58.66% |
| 2018-12-31 | -2095.10% |
| 2016-12-31 | -205.93% |
| 2015-12-31 | -102.13% |
| 2014-12-31 | -139.28% |
| 2013-12-31 | -303.39% |
| 2011-12-31 | -55.05% |
| 2010-12-31 | -501.82% |
| 2009-12-31 | -55.36% |
| 2008-12-31 | -103.28% |
| 2007-12-31 | -98.38% |
| 2006-12-31 | -87.92% |
| 2005-12-31 | -76.26% |
| 2004-12-31 | -41.08% |
| 2003-12-31 | -65.54% |
| 2002-12-31 | -104.18% |
| 2001-12-31 | -81.36% |
| 2000-12-31 | -58.67% |
| 1999-12-31 | -27.92% |
| 1998-12-31 | -12.07% |
